Lueftner, Diana; Brucker, Cosima; Decker, Thomas et al.
Real-world efficacy of ribociclib (RIB) plus aromatase inhibitor (AI)/fulvestrant (FUL), or endocrine monotherapy (ET), or chemotherapy (CT) as first-line (1L) treatment (tx) in patients (pts) with hormone receptor-positive (HR plus ), human epidermal growth factor receptor-2-negative (HER2-) advanced breast cancer (ABC): Results of fourth interim analysis (IA) from RIBANNA.JOURNAL OF CLINICAL ONCOLOGY. Bd. 40. H. 16. 2022
Luftner, Diana; Brucker, Cosima; Decker, Thomas et al.
Real-world efficacy of ribociclib plus aromatase inhibitor/fulvestrant, or endocrine monotherapy, or chemotherapy as first-line treatment in women with hormone receptor-positive (HR plus ), human epidermal growth factor receptor-2-negative (HER2-) locally advanced or metastatic breast cancer: Fourth interim analysis from the RIBANNA studyCANCER RESEARCH. Bd. 82. H. 4. 2022
Lazarus, Jeffrey V.; Castera, Laurent; Mark, Henry et al.
REAL-WORLD EVIDENCE ON NON-INVASIVE TESTS AND ASSOCIATED CUT-OFFS USED TO ASSESS FIBROSIS IN ROUTINE CLINICAL PRACTICEHEPATOLOGY. Bd. 76. 2022 S. S818-S820
Hess, Georg; Dreyling, Martin; Oberic, Lucie et al.
Real-world experience among patients with relapsed/refractory mantle cell lymphoma after Bruton tyrosine kinase inhibitor failure in Europe: The SCHOLAR-2 retrospective chart review studyBRITISH JOURNAL OF HAEMATOLOGY. 2022
Wolfram, Christian; Pfeiffer, Norbert; Hudde, Tobias et al.
Real-world outcomes of anti-VEGF therapy: psychological, social and behavioral factors measured by the ALBATROS data collection instrument BPZ-9INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE. Bd. 63. H. 7. 2022
Schumann, Katharina; Mauch, Cornelia; Klespe, Kai-Christian et al.
Real-world outcomes using PD-1 antibodies and BRAF plus MEK inhibitors for adjuvant melanoma treatment from 39 skin cancer centers in Germany, Austria and SwitzerlandJOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2022
Mohr, Peter; Scherrer, Emilie; Assaf, Chalid et al.
Real-World Therapy with Pembrolizumab: Outcomes and Surrogate Endpoints for Predicting Survival in Advanced Melanoma Patients in GermanyCANCERS. Bd. 14. H. 7. 2022
Buhl, Roland; Wilke, Thomas; Picker, Nils et al.
Real-World Treatment of Patients Newly Diagnosed with Chronic Obstructive Pulmonary Disease: A Retrospective German Claims Data AnalysisINTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE. Bd. 17. 2022 S. 2355-2367
Haxel, Boris R.; Hummel, Thomas; Fruth, Kai et al.
Real-world- effectiveness of biological treatment for severe chronic rhinosinusitis with nasal polyps*RHINOLOGY. Bd. 60. H. 6. 2022
Moehler, Markus; Hoegner, Anica; Wagner, Anna D. et al.
Recent progress and current challenges of immunotherapy in advanced/metastatic esophagogastric adenocarcinomaEUROPEAN JOURNAL OF CANCER. Bd. 176. 2022 S. 13-29